Acrivon Therapeutics, Inc. SEC filings ACRV
Acrivon Therapeutics, Inc. has 346 filings in SEC EDGAR's recent list, going back to Feb 12, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 26, 2026 | Oct 22, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 3 | Initial insider ownership | Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Aug 27, 2026 | Aug 25, 2026 |
| 144 | Notice of proposed sale | Aug 25, 2026 | — |
| 4 | Insider transaction | Aug 20, 2026 | Aug 18, 2026 |
| 4 | Insider transaction | Aug 20, 2026 | Aug 18, 2026 |
| 4 | Insider transaction | Aug 20, 2026 | Aug 18, 2026 |
| 4 | Insider transaction | Aug 20, 2026 | Aug 18, 2026 |
| 4 | Insider transaction | Aug 20, 2026 | Aug 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| S-8 | Employee stock plan registration | Aug 12, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Aug 6, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| DEFA14A | Additional proxy material | May 22, 2026 | — |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 17, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 23, 2026 | — |
| 4 | Insider transaction | Apr 23, 2026 | Apr 22, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 17, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 23, 2026 | — |
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2026 | Mar 19, 2026 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 2, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 27, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 17, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 15, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 21, 2025 | — |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 17, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2025 | Sep 5, 2025 |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Jul 21, 2025 | Jul 17, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 4, 2025 | — |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| S-8 | Employee stock plan registration | May 14, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 1, 2025 | — |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 29, 2025 | Apr 25, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 13, 2025 |
| 3 | Initial insider ownership | Apr 21, 2025 | Apr 9, 2025 |
| 4 | Insider transaction | Apr 18, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 7, 2025 | Apr 7, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 3 | Initial insider ownership | Apr 3, 2025 | Apr 1, 2025 |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Nov 27, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 11, 2024 | Oct 11, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2024 | Sep 14, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 17, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2024 | — |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | May 21, 2024 | May 17, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACRV (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Watertown, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1781174
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.